Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No CommentsChemoinformatics is a relatively new principle of chemistry and is based upon the processing of data concerning chemical and molecular structures through the use of…
By pharmatrax
Category: News
No CommentsThere are plenty of reasons to be cautious about the stock market in 2020, but companies like these are likely to pay off. American stock…
By pharmatrax
Category: News
No CommentsThe United States has seen the call back of major drugs in the nation as well as in the international markets where the US-based companies…
By pharmatrax
Category: News
No CommentsSome pharmaceutical manufacturers can struggle to keep microorganisms away from their facilities, which sometimes goes unnoticed until it is too late. While there are numerous…
By pharmatrax
Category: News
No CommentsThe Medicines and Healthcare Regulatory Agency (MHRA) has issued a drug alert, as Creo Pharma Limited and Tillomed Laboratories have recalled their unexpired stock of…
By pharmatrax
Category: News
No CommentsThe medicines affected are prescription-only and not sold over the counter Supplies of ranitidine, the generic ingredient, are affected in the UK and US Medicine…
By pharmatrax
Category: News
No CommentsGlaxoSmithKline (GSK) and Teva UK have recalled their ranitidine products in October (Photo: REUTERS/Brendan McDermid/Illustration) OTC Concepts Ltd, Relconchem Ltd, Noumed Life Sciences Ltd, and Medreich Plc…
By pharmatrax
Category: News
No CommentsIn 1963, during the 16th World Health Assembly, a resolution passed for the monitoring of adverse drug incidents which led the formation of the WHO…
By pharmatrax
Category: News
No CommentsThe supermarket products were among 13 new additions to an ongoing recall Products in the UK and US have been taken off shelves due to…
By pharmatrax
Category: News
No CommentsA few inspectional observations made by the US Food And Drug Administration (USFDA) on Aurobindo Pharma Ltd’s Unit-4 earlier this month appear to be quite serious and…